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Förbättrad positionering av bröstcancerpatienter som genomgår 
strålbehandling 
Cirka 30 000 kvinnor får diagnosen cancer varje år i Sverige [1]. Av dessa utgör bröstcancer den 
vanligaste diagnosen med över 9000 fall per år [2]. Cancern kan vara begränsad till endast bröstet, men 
kan också ha spridit sig till de intilliggande lymfkörtlarna. Behandling av bröstcancer med 
körtelengagemang inleds vanligtvis med kirurgi och därefter är det vanligt att patienten även får 
strålbehandling. Syftet med detta är att, med hjälp av strålningen, eliminera de tumörceller som 
fortfarande kan finnas kvar efter operationen och på så sätt minska risken för att en ny tumör börjar 
växa. På Skånes Universitetssjukhus i Lund delas strålbehandlingen för bröstcancerpatienter med 
körtelengagemang upp på 25 fraktioner. Patienten får en lika stor stråldos vid varje behandlingstillfälle. 
Innan strålbehandlingen påbörjas genomgår patienten datortomografi., som genom röntgenteknik 
genererar snittbilder av patienten. Vid detta tillfälle positioneras patienten i en fixation som ska användas 
under alla kommande behandlingstillfällen. Fixationen säkerställer att patienten ligger still och likadant 
under hela behandlingen. Utifrån datortomografin görs sedan en stråldosplan, i vilken man bestämmer 
hur strålningen ska ges och med vilka maskininställningar.  
Vid strålbehandling är det viktigt att endast tumörområdet bestrålas och att den friska vävnaden skonas 
i så stor utsträckning som möjligt. En viktig del för att uppnå detta utgörs av att patienten ligger korrekt 
positionerad varje dag vid behandlingen. Det konventionella sättet att positionera patienten inför 
behandling är att använda sig av ett laserbaserat koordinatsystem som finns inne i behandlingsrummet 
samt markeringar som ritas på patientens hud vid datortomografin. När laser och hudmarkeringar 
sammanfaller antar man att patienten är korrekt positionerad. För att verifiera patientens position tas 
röntgenbilder på patienten innan behandlingen startas. Detta görs de tre första fraktionerna och därefter 
en gång i veckan. Röntgenbilderna matchas mot referensbilder från CT-skanningen och när dessa bilder 
överlappar vet man att patienten kommer få sin behandling till rätt område. De dagar som 
verifikationsbilder inte tas, positionerar man patienten endast utifrån laser och hudmarkeringar. Trots 
att patienten är fixerad finns det utrymme för rörelse. Patientrörelser kan påverka tumörområdets 
position, utan att detta kan upptäckas med laser och hudmarkeringar. För bröstcancerpatienter påverkas 
bestrålningsvolymens position exempelvis av armens position, som är placerad ovanför huvudet. 
Eftersom inga hudmarkeringar ritas på patientens armar finns det risk för att en sådan felpositionering 
inte upptäcks och patienten får inte den stråldos till den volym som var planerat. 
För att förbättra patientpositioneringen under strålbehandling har optiskt ytskanning utvecklats, vilket 
bygger på att synligt ljus skannar av en vald volym av patientens yta medan hen ligger på britsen. Med 
hjälp av det reflekterade ljuset från patienten kan systemet beräkna patientens position i rummet och 
därmed upptäcka en eventuell felpositionering av patienten. Ljuset som patienten skannas med är 
vanligt, synligt ljus och ger därför ingen extra stråldos. Eftersom det är en hel volym av patienten som 
skannas kan exempelvis felpositionerade armar hos bröstcancerpatienter upptäckas och justeras. 
I detta examensarbete undersöktes om patientpositioneringen av bröstcancerpatienter med 
körtelengagemang kunde förbättras genom att positionera patienterna med ett optiskt 
ytskanningssystem. Studien genomfördes genom att patienter positionerades med detta optiska 
ytskanningssystem, istället för med laser och hudmarkeringar. För alla fraktioner där röntgenbilder togs 
noterades avvikelsen mellan dagens bild och referensbilden. Dessa siffror jämfördes därefter med 
motsvarande siffror från patienter som hade lagts upp med hjälp av laser och hudmarkeringar för att 
undersöka om optisk ytskanning bidrog till mindre avvikelser i positioneringen. 
Studiens resultat visar på en förbättring av patientpositioneringen då optisk ytskanning används. Detta 
innebär att patienten kan positioneras med en god noggrannhet även de dagar då verifikationsbilder inte 
tas, utan att erhålla någon extra stråldos från röntgenbildtagning. Med hjälp av bättre daglig 
patientpositionering får patienten även en bättre behandling eftersom rätt volym blir bestrålad. 
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Abstract 
Purpose: The overall purpose of this master thesis was to investigate if the patient positioning could be 
improved for breast cancer patients with nodal involvement, using the optical scanning system Catalyst 
during patient setup. Patient motion during treatment and the effect it has on the dose distribution was 
also investigated. 
Materials and Methods: Eleven patients positioned according to the Catalyst and 10 patients positioned 
according to the conventional laser and skin markings based setup (LBS) were enrolled in this study. To 
evaluate if positioning was improved with the surface based setup (SBS), the setup deviations arising 
from matching daily verification images to the reference images were acquired for both positioning 
methods. The setup deviations were then compared between the different methods by studying the 
distribution of deviations. The systematic and random setup deviations and PTV margin were also 
determined for both groups. In total, 127 fractions of patients positioned with LBS and 93 fractions of 
patients positioned with SBS were analysed. To investigate what impact the offline correction strategy 
used at Skåne University Hospital (SUS) has on the positioning, the data was analysed both with and 
without the offline corrections applied.  
The dosimetric effect of patient motion was evaluated for one patient by analysing recorded motion data 
during beam delivery by the Catalyst system in terms of isocenter shift. All isocenter shifts that occurred 
when the beam was on were extracted and added to the original patient position to get the total isocenter 
shift, including both inter- and intrafractional motion. The mean isocenter shift for each fraction was 
determined and the isocenter position was shifted in the original treatment plan for each fraction in the 
treatment planning system (TPS). The dose was then re-calculated for each fraction and summed to one 
plan that was compared to the original dose distribution.  
Results: The obtained results indicate that SBS is a better method of positioning patients than LBS. For 
LBS, with offline corrections included, the amount of fractions where setup deviation exceeded the 
clinical setup deviation threshold of 4 mm was 22% / 21% / 28% in vrt/lng/lat. The corresponding values 
for SBS were 7.5% / 6.5% / 20% in vrt/lng/lat. The systematic and random setup error was smaller with 
Catalyst setup in all directions and the PTV margin could be reduced in the lng direction for SBS, 
compared to LBS. 
The setup deviations were also evaluated for LBS and SBS, both with and without the offline corrections 
applied. The results showed that although it is important to use the correction strategy for LBS, SBS did 
not depend on the correction strategy and the positioning was not improved as much for this method. 
No large impact on the DVH could be seen for the PTV of the summed treatment plan where the 
isocenter was shifted to a mean position for each fraction. D98% of the original plan was 46.6 Gy. D98% 
for the plan where the isocenter was shifted was 46.5 Gy. The absorbed dose to the heart and left lung 
was lower than in the original plan and the absorbed dose to the spinal cord was slightly increased. The 
difference between the plans was not clinically relevant. 
Conclusions: The amount of setup deviations exceeding 4 mm was decreased in all directions for SBS 
compared to LBS. Also, both the systematic and random setup error was decreased for SBS. The 
correction strategy improved the positioning for LBS, while the SBS did not depend as much on the 
corrections. The DVH of one patient with considerable motion during treatment indicated that the dose 
distribution was not affected to any large extent, when inter- and intrafractional motion was considered. 
However, to be able to draw any definite conclusions about the dosimetric effect due to patient motion 
more patients have to be evaluated. 
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Abbreviations 
 
AML Adaptive Most Likelihood 
CBCT Cone Beam Computed Tomography 
CTV Clinical Target Volume 
DRR Digitally Reconstructed Radiograph 
DVH Dose Volume Histogram 
LAT Lateral 
LBS Laser/skin markings Based Setup 
LNG Longitudinal 
MVCT Mega Voltage Computed Tomography 
NAL No Action Level 
OAR Organs at Risk 
PTV Planning Target Volume 
ROT Rotation 
SBS Surface Based Setup 
TPS Treatment Planning System 
VRT Vertical 
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1. Introduction 
More than 60 000 people are diagnosed with cancer every year in Sweden [2]. Half of these are at some 
point treated with radiotherapy [3]. Radiotherapy aims to irradiate a target volume, with a high radiation 
dose, while sparing the surrounding healthy tissue as much as possible. To achieve the best treatment 
results the patient must be positioned correctly, according to the planning CT, and in the same way 
during all treatment sessions. Another factor that can affect the outcome of radiotherapy is intra- and 
interfractional patient motion during the treatment course. Intrafractional motion is patient motion that 
occurs during a treatment session. Such motion is due to, for instance, respiration, swallowing or 
gastrointestinal motion. Interfractional motion is the patient related difference that occurs from one 
treatment session to another. These differences can, for example, be caused by weight gain or loss, 
variance in the filling of the bladder or different patient position between treatment sessions. Without 
good accuracy in the radiation delivery, there is a risk of not covering the target volume and instead 
deliver radiation to normal tissue. This can lead to radiation induced cancer or that the patient is not 
cured [4]. 
During delineation of the tumour and organs at risk (OAR) the physician delineates the clinical target 
volume (CTV) which is the tumour site with margins for microscopic cancer cells. Since, for instance, 
patient breathing motion and day-to-day variability in patient setup is inevitable, a margin to the CTV 
is added to account for deviations in patient positioning. The new volume is called planning target 
volume (PTV) and is the volume to be irradiated [5]. 
The conventional way of positioning the patients is to use a laser based coordinate system and external 
skin markings. When the patient is positioned so that the lasers and markings align, it is assumed that 
the PTV is in the correct position. To avoid patient motion during treatment, the patients are positioned 
in a fixation system. The choice of fixation depends, amongst other things, on the target and what best 
ensures that the patient can lie in the same position as during the planning CT. The fixation also prevents 
the patient from moving for instance arms and legs during treatment. 
A cause for concern regarding skin markings is that they give poor information about the location of the 
internal PTV. Patient motion can affect the treatment of the tumour and movements of the patient can 
in turn lead to displacement of the PTV, while the skin markings still align with the lasers. It is for 
instance of great importance for breast cancer patients that the arms and chin are positioned correctly. 
Arm movements can have an impact on the pendulous breast tissue, an impact which may not be detected 
by just examining the external markings. Although the patients are positioned in a fixation during 
treatment, it is still possible for them to move certain parts of their body to some degree and this can 
lead to displacements of the target [4]. 
To ensure the position of the patient imaging is performed at the start of the treatment course. These 
images are matched to reference images from the planning CT and if necessary, the position of the 
patient is adjusted by moving the couch to the correct position. The patient setup deviation is defined as 
the difference between the reference images and the verification images acquired prior to treatment. The 
setup deviation has a systematic and a random component and both affect the dose distribution to the 
target. Systematic deviations entail a difference between the planned and mean patient position and are 
present at all fractions. Random setup deviations arise due to day-to-day variations in the patient 
positioning and is the distribution of the patient position for every fraction around the mean position. 
The number of daily images that is acquired during the whole treatment course depends on for instance 
number of fractions and fraction dose. At SUS, for patients without fiducial markers whose treatment 
consists of a fraction dose below 7 Gy and more than 5 treatment sessions, images are acquired the first 
three fractions and once a week after that. After the first three fractions the size of the systematic 
deviation is estimated and is corrected for if necessary the following fractions throughout the treatment. 
With subsequent, continuous imaging, systematic setup deviations can be discovered during the rest of 
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the treatment course. During the fractions without imaging the patient is positioned according to the 
laser and skin markings only. 
With evolving radiotherapy techniques, optical surface scanning imaging has been developed to improve 
the positioning of patients undergoing radiotherapy. At SUS the optical surface scanning system used is 
the Catalyst (C-Rad Positioning AB). The Catalyst uses nonionizing radiation to compare a reference 
surface of the patient from the CT with a live surface in the treatment room, and detect deviations 
between these different surfaces. Optical surface scanning can thus ensure that the total scanned volume 
is in the same position as in the reference situation. Furthermore, the Catalyst uses optical triangulation 
and a non-rigid algorithm to calculate where the isocenter in the PTV is located. During treatment the 
Catalyst can be used for motion monitoring, displaying how much the current isocenter position deviates 
from the planned position. If the patient motion exceeds the predetermined limits, the beam can be 
interrupted and the patient’s position can be re-adjusted.  
It has been shown that patient setup can be improved with surface scanning [4], [6–12]. The use of 
surface scanning can decrease setup deviations without delivering any additional radiation dose to the 
patient.  
At the radiotherapy department at SUS in Lund, breast cancer patients with nodal involvement are 
normally positioned with lasers and skin markings. This positioning method is initiated with placing a 
small lead marker in the middle of the patient’s thorax before the planning CT scan. The patient is also 
given a tattoo at the site of the lead marker. The marker is visible on the CT images and is an external 
reference point. The location of the internal isocenter in the target volume is set during the dose planning 
and the distance between the external reference point and the internal isocenter is determined in the vrt, 
lng and lat direction in the TPS. During the first treatment session, the patient is initially positioned with 
the laser and tattoo aligning. The treatment personnel then move the couch the predetermined distance 
in the vrt, lng and lat direction to obtain the isocenter in the correct position. External skin markings are 
after this drawn on the patient at the site of the laser to mark the correct treatment position in vrt, lng 
and lat.   
To verify the patient positioning, two orthogonal setup x-ray images and one setup field image is 
acquired the first three fractions and after that once a week. The images are matched to the digitally 
reconstructed radiograph (DRR) reference image from the planning CT, with respect to the bony 
anatomy. The frontal image is matched in the lat direction with respect to the inner part of the rib cage 
including the vertebrae. In the lng direction, the frontal image is matched with respect to the medial 
parts of the clavicle. The orthogonal image, taken from the side, is matched with respect to the sternum 
in the vrt direction. The field image ensures that the breast is within the field.  
Kügele et al. [6] has shown that the positioning of breast cancer patients without nodal involvement, 
treated with tangential fields, is improved when the patients are positioned using the Catalyst, and as a 
result of this study this patient group is today positioned with the Catalyst only at SUS.  
Crop et al. [7] compared patient setup between positioning with Catalyst and laser by examining the 
difference between initial positioning and final position after imaging with mega voltage computed 
tomography (MVCT). The study involved breast cancer patients with nodal involvement treated with 
Tomotherapy. The study showed that patient positioning with Catalyst was more precise than laser 
positioning. The results also indicated that Catalyst can provide an accuracy in patient setup equal to 
MVCT for breast cancer patients. 
Stieler et al.[12] evaluated the calculated isocenter position by Catalyst compared to matching a cone 
beam computed tomography (CBCT) to the planned isocenter position. The study showed a good 
agreement between the Catalyst and CBCT and indicated good accuracy for the isocentric calculation 
performed by Catalyst. At the time of the study by Stieler et al. Catalyst used a rigid algorithm for 
surface matching. These authors noted that an elastic algorithm was likely to provide an even better 
accuracy for patient setup using Catalyst [12]. 
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During this study, the position of the isocenter was determined utilizing a novel non-rigid algorithm that 
includes information about the whole PTV volume when calculating the position of the isocenter. This 
algorithm is an option in the Catalyst system and provides a more solid calculation of the isocenter 
position. 
1.1 Aim 
The aim of this master thesis was to evaluate if the patient positioning could be improved for breast 
cancer patients with lymph node involvement, by positioning the patients according to the optical 
surface scanning system Catalyst (C-Rad Positioning AB) during setup using the novel PTV-based 
algorithm, compared to the conventional laser/skin markings based setup. 
An additional aim was to evaluate the dosimetric effects of potential isocenter shift due to inter- and 
intrafractional motion of the patient.   
Questions to be answered were: 
• Can the positioning of breast cancer patients with lymph node involvement be improved using 
the optical surface scanning system Catalyst during patient setup? 
• To what extent is the dose distribution affected by the patient’s potential movements during 
beam on? 
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2. Theory 
2.1 Patient Setup Deviations 
A patient setup deviation occurs when there is a difference between the intended volume to be irradiated 
and the actual volume that is irradiated. The deviations can be measured by registering the difference 
between the DRR from the CT scan and the daily verification image. 
Patient setup deviation can be divided into systematic and random deviations. A systematic deviation 
cause a difference between the mean patient position and the planned patient position. Systematic 
deviations are associated with treatment preparation variations and are present at all fractions.  A 
systematic deviation can for instance be introduced from tumour delineation variability. Random setup 
deviations describe the distribution of the patient position around the mean position. Since random 
deviations correspond to the day-to-day setup variations, these deviations vary between different 
fractions and can for example arise from organ motion [13]. 
Both systematic and random deviations have an impact on the delivered dose to the target and the OAR. 
The systematic deviations lead to a shift of the dose distribution from the planned target position. Since 
the random deviations differs from day to day, these errors cause the dose distribution to be blurred. The 
systematic and random deviations need to be taken into account when the PTV margin for the CTV is 
determined [14]. Illustrations of systematic and random setup deviations can be seen in Figure 1 and 
Figure 2. The appearance and position of the dose distribution can be correlated to the distribution of 
the patient position displayed in the figures. Figure 1 shows how the treatment is affected by a systematic 
setup deviation. The mean patient position is shifted, and although the patient is positioned with high 
precision at every fraction, the systematic deviation will still cause a difference between the intended 
and actual treated volume throughout the whole treatment. Figure 2 demonstrates how random 
deviations influence the distribution of the patient position; with a larger random deviation, more 
blurring of the dose distribution will arise. It can also be noted that for both good and poor precision in 
daily patient setup, the mean patient position can be the same. 
Random deviations are best prevented by using good immobilization equipment and to ensure that the 
patient setup is reproducible. In order to avoid systematic deviations a correction strategy should be used 
[15].  
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(a) 
 
(b) 
Figure 1. Mean patient position shift introduced by a systematic deviation in one direction (a) and two directions (b). The dashed, black vertical line in (a) 
corresponds to the mean patient position if there was no systematic setup deviation present, whereas the solid, black line represents the resulting mean patient 
position from a systematic deviation. Each square and triangle in (b) is equivalent to a measurement of the patient position for one fraction, where the origin 
corresponds to the planned position. The arrows illustrate the direction and size of the systematic deviation. 
 
 
 (a) 
 
 (b) 
Figure 2. How the patient setup distribution is affected when random deviations of different size are introduced, illustrated in one (a) and two (b) directions. 
The black, vertical line in (a) represent the mean patient position around which the random deviations are distributed. Every square and triangle in (b) 
correspond to one patient setup position, and they are all distributed around the same mean; the origin. The arrows illustrate the size of the random deviation.  
 
2.1.1 Determination of Systematic and Random Errors 
To be able to separate systematic from random deviations by examining the difference between the DRR 
and the verification x-ray images, several images need to be taken for every patient. The accuracy of the 
analysis of the systematic and random deviations depends on the number of patients, P, and the number 
of images, N, acquired [16].  
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Eq. 1-6 describe how to determine the systematic, Σ, and random, σ, setup error and if the overall mean 
systematic deviation is statistically significant. In Table 1 explanations to the notations used in Eq. 1-6 
can be seen. 
Table 1. Explanations to the notations used in Eq. 1-6. 
Symbol Explanation 
𝑖 Image number 
𝑝 Patient number  
𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 Deviation between the DRR and the setup image in a given direction 
𝑛𝑝 Number of images acquired for patient 𝑝 
𝑁 Total number of images included in the study 
𝑃 Total number of patients included in the study 
𝑚𝑝 Mean position deviation for patient 𝑝, i.e. the individual systematic deviation for 
patient 𝑝 in a given direction 
𝑚𝑜 Overall mean systematic deviation in a given direction, i.e. the mean of 𝑚𝑝 for all 
patients 𝑃 
𝜎𝑝 The standard deviation of the distribution of 𝜇DRR−setup for patient 𝑝 in a given 
direction, i.e. the individual random setup deviation 
σ The standard deviation of the distribution of 𝜎𝑝, i.e. the random setup error for all 
patients 𝑃 in a given direction 
Σ The standard deviation of the distribution of 𝑚𝑝, i.e. the systematic setup error for 
all patients 𝑃 in a given direction 
 
 
The individual systematic error, 𝑚𝑝, is defined as the mean of all measured deviations between the DRR 
and the setup images, 𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝, for one patient, in a given direction, according to Eq. 1. An individual 
systematic deviation could for instance arise from a misplaced skin tattoo.  
𝑚𝑝 =
1
𝑛𝑝
∑ 𝜇(𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝)𝑖
𝑛𝑝
𝑖=1
 
(1) 
 
The individual random deviation, 𝜎𝑝, is the standard deviation of the μDRR-𝑠𝑒𝑡𝑢𝑝-distribution for one 
patient and can be determined according to Eq. 2.  
𝜎𝑝 = √
1
𝑛𝑝 − 1
∑(𝜇(𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝)𝑖 − 𝑚𝑝)
2
𝑛𝑝
𝑖=1
 
(2) 
 
 
The overall mean systematic deviation, 𝑚𝑜, for all patients is defined as the mean of 𝑚𝑝 and is defined 
as 
𝑚𝑜 =
1
𝑁
∑ 𝑛𝑝 ∙ 𝑚𝑝
𝑃
𝑝=1
 (3) 
 
It follows from Eq. 3 that 𝑚𝑜 is the mean that the values of 𝑚𝑝 are distributed around and that the 
equation takes the number of images acquired for every patient into account. Whether 𝑚𝑜 is statistically 
significantly nonzero, can be determined accordingly [17]: 
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|𝑚𝑜| > 𝑡 ∙
Σ
√𝑃
 (4) 
 
where 𝑡 is the constant of the t-distribution for 𝑃 − 1 degrees of freedom at the 95 % confidence level. 
If 𝑚𝑜 is statistically significant, there is a systematic deviation that affects all patients. This could for 
example be a misaligned laser in the treatment room.  
For a patient population, the systematic error, Σ, which is the standard deviation of 𝑚𝑝, can be 
determined by Eq 5. 
Σ = √
𝑃
𝑁(𝑃 − 1)
∑ 𝑛𝑝(𝑚𝑝 − 𝑚𝑜)
2
𝑃
𝑝=1
 (5) 
 
 
The random setup error for the whole patient population, 𝜎, is the standard deviation of the distribution 
of the individual random deviations, see Eq. 6. 
𝜎 = √
1
𝑁 − 𝑃
∑ 𝜎𝑝
2
𝑃
𝑝=1
(𝑛𝑝 − 1) 
(6) 
 
 
2.1.2 Patient Setup Correction Strategy 
At SUS the strategy used to correct for systematic deviations is No Action Level (NAL) in combination 
with the Adaptive Most Likelihood (AML) strategy [17]. According to Månsson et al. [17] this is the 
optimal correction strategy to be used at SUS.  
For the NAL strategy, setup images are acquired during the first 𝑛𝑝 fractions and thereafter the mean 
setup deviation for these first fractions is determined. The patient position is then corrected according 
to the calculated mean deviation for the following fractions [18]. 
The AML strategy is based on a correction factor, 𝑘, which takes the systematic and random setup errors 
into account during the calculation, according to Eq. 7, where 𝑛 is the number of images [16]. 
𝑘 =
𝑛Σ2
𝑛Σ2 + 𝜎2
 (7) 
 
According to Månsson et al. [17] the systematic and random setup deviations are approximately equal, 
and therefore the correction factor used at SUS is instead the one seen in Eq. 8. 
𝑘𝑆𝑈𝑆 =
𝑛
𝑛 + 1
 (8) 
 
For breast cancer patients with nodal involvement which are treated at SUS, setup images are acquired 
during three first fractions. The mean displacement is then calculated in the vrt, lng and lat direction and 
multiplied with the correction factor 𝑘𝑆𝑈𝑆. If the result is equal to or greater than the permanent 
correction level a permanent correction of the patient position is performed (Table 2). 
If, during the first three fractions, 𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 is equal to or larger than 5 mm an online position 
correction is done. From fraction 4 and onwards the acute action level is instead 4 mm, see Table 2. 
After the third fraction setup images are acquired once a week. In the case of 𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 being equal to 
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or larger than 4 mm after the third fraction, an online correction is performed and setup images are 
acquired during the following fraction as well. The correction strategy is then applied on the result from 
these two fractions to determine if a permanent position correction should be done.  
Table 2. The imaging modality, imaging protocol and action levels for breast cancer patients with nodal involvement, treated with radiotherapy, at SUS. 
Imaging modality 
Acute action level, 
fraction 1-3 
[mm] 
Acute action level, 
fraction 4-25 
[mm] 
Action level, 
permanent correction 
[mm] 
Imaging 
protocol 
Elekta: Setup MV/MV + field MV 
Varian: Setup kV/kV + field MV 
5 4 3 
Fraction 1-3 + 
1/week 
 
 
2.1.3 Determination of PTV-margin  
Since both systematic and random deviations affects the dose distribution, a margin must be added to 
the CTV to account for the deviations. The new volume is the PTV and the distance between the PTV 
and CTV is called the PTV margin. M van Herk et al. [14] analysed how much the dose distribution is 
affected by systematic and random deviations and developed a recipe for how to determine the 
appropriate PTV margin, see Eq. 9. 
PTV𝑚 = 2.5Σ + 0.7𝜎 (9) 
 
Eq. 9 applies for a 95 % dose coverage to the CTV, for 90 % of the patients. 
2.2 The Optical Surface Scanning System 
The optical surface scanning system Catalyst is a system used within radiotherapy for patient positioning 
and monitoring. The system utilizes optical surface scanning in order to determine the position and 
movements of the patient before and during treatment sessions. The Catalyst unit, mounted on the 
ceiling, consists of a LED projecting visible light on the patient and a camera detecting the reflected 
light from the patient. With the information from the reflected light the system can calculate the distance 
to the object and create a 3D surface using optical triangulation [19]. The Catalyst can also estimate the 
position of the isocenter relative to a reference using a non-rigid algorithm [20]. 
Both three unit systems (Catalyst HD) and single unit systems exist. With three cameras, the system can 
scan up to 200 scans/s and the patient positioning and motion detection accuracy is within 0.5 mm. For 
the one camera system, the scan speed is 80 scans/s and the accuracy for both patient positioning and 
motion detection is within 1 mm. Both systems can scan a volume size of 800 mm x 1300 mm x 700 
mm in the lateral (lat), longitudinal (lng) and vertical (vrt) direction [21], [22]. 
When importing a patient to the Catalyst system an appropriate template is chosen which determines the 
tolerance for isocenter shift and surface shift. These tolerances can also be set manually if needed. 
During the Catalyst import the size of volume to be scanned is defined. The skin rendering structure 
from the CT scan is included during the patient import and this structure forms the reference surface for 
the patient positioning. If the patient is re-positioned at some point during the course of treatment, a new 
reference image can be acquired in the Catalyst system. 
The Catalyst can be used for positioning the patient in the cPosition-mode and monitor the patient’s 
movements during treatment in the cMotion-mode. The Catalyst can also be used for respiratory gated 
treatments in the cRespiration-mode, however this mode was not used in this study and will therefore 
not be further explained. 
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2.2.1 Patient Positioning 
In the application cPosition, the system analyses the amount of deviation for a live surface relative to 
the reference surface. The live surface is generated through the reflection of the projected light (𝜆 = 405 
nm) on the patient and is updated continuously [21]. If the scanned volume results in a poor live surface 
with loss of signal in several parts of the surface, the settings “Time” and “Gain” can be adjusted. Time 
represents the exposure time and gain is the saturation.  
The live and reference surfaces and the calculated isocenter shift can both be seen on the Catalyst 
computer screen in the treatment room. Figure 3 shows an example of a reference and live surface. 
Deviations between the live surface and the reference surface exceeding the tolerance level will be 
displayed as different colours projected on to the patient’s surface, depending on how the patient is 
displaced. A green light (𝜆 = 528 nm) indicates that the patient is positioned too low and a red light 
(𝜆 = 624 nm) indicates that the patient is positioned too high, in comparison with the reference surface, 
see Figure 4 [21]. By using the projected colour map, any patient rotation can also be detected. The 
patient position should be adjusted according to the projected colourmap so that the live and reference 
surfaces align. Once the surfaces are aligned within the pre-set tolerance level, the projected light turns 
transparent.  
 
 
(a) 
 
(b) 
Figure 3. Example of a reference surface (a) and live surface (b) in the Catalyst system. 
 
 
(a) 
 
(b) 
Figure 4. The resulting colormap when the reference and live surfaces are not aligned, shown on the 
Catalyst display in the treatment room (a) and projected on to the surface of a patient (b). 
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When the calculated isocenter of the live surface differs from the reference isocenter more than the set 
template, the numbers on the Catalyst screen will appear red. These numbers instruct the treatment 
personnel how much and in what direction the patient should be moved to enable the calculated isocenter 
to coincide with the reference isocenter. Once the real-time calculated isocenter is in the correct position, 
the numbers on the display will cease being red. The isocenter shift is calculated in 6 degrees of freedom; 
vrt, lng, lat, rotation (rot), roll and pitch. Figure 5 shows an illustration of how a patient displacement 
results in red numbers and how it looks once the patient is in the correct position.  
 
 
(a) 
 
(b) 
Figure 5. Deviation between the reference and live surface resulting in red numbers (a) and the reference and live surface aligned (b). 
 
2.2.2 Patient Motion Monitoring 
After the patient has been placed in the correct treatment position, the cMotion-mode can be entered. In 
this mode, the patient’s movements can be monitored during the treatment delivery. When entering 
cMotion, the live surface from cPosition becomes the reference surface for that specific monitoring. The 
Catalyst continuously monitors if the patient moves relative to the position determined during patient 
setup. The calculated motion induced isocenter shift are displayed as bars in a diagram (Figure 6). The 
isocenter shift displayed represent the length of the vector combining the deviations in the vrt, lng and 
lat direction. If the patient moves in a way that leads to an isocenter vector shift exceeding the tolerance 
level the green bars in the diagram become red. The beam can then be interrupted and the patient’s 
position adjusted back to the correct position. The interruption of the beam can be installed to be 
automatic. If the beam interruption is not automatic, the beam must be stopped manually. This means 
that even though the movements of the patient cause an isocenter vector shift exceeding the tolerance 
level, it is possible to continue irradiating the patient. This possibility can be seen in Figure 6, where the 
treatment has been carried out despite the occasional large patient motion.  
Every isocenter shift that is registered in cMotion is saved and can be analyzed. The information saved 
include elapsed time and shifts in the lat, lng and vrt direction and the rot, pitch and roll of the patient. 
The isocenter shift vector and if the beam was on or off is also registered. 
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Figure 6. An example of a diagram resulting from monitoring a breast cancer patient, with nodal involvement, in cMotion. The bars show the isocenter 
vector shift from the reference. The red bars represent movements of the isocenter larger than 4 mm. The time displayed is the time elapsed since cMotion 
was entered and the grey blocks below the bars indicates beam on. 
2.2.3 Isocenter Shift and PTV algorithm 
The system uses a non-rigid algorithm in the calculation of the isocenter shift. A non-rigid algorithm 
accounts for deformations of the scanned object that have occurred between the source scan (reference 
surface) and the target scan (live surface) [23]. To determine the isocenter shift, the amount of 
deformations in the source scan must be determined first. 
The Catalyst system uses optical triangulation to create a 3D triangle mesh for both the source and target 
scan. Both rigid and non-rigid deformations of the source can occur and these are all unknown. 
Therefore, the deformation of the source mesh has to be calculated, to find a deformed source scan that 
matches the target scan [20]. 
A deformation graph is created for the source scan (Figure 7). Every individual node in the graph is 
associated to both a linear representation and a translation and induces a deformation on the adjacent 
region in the graph. All nodes together therefore describe the non-rigid deformation of the scan and the 
graph. The rigid deformations are modelled separately and are modelled for the whole graph at once, 
instead of one node at a time. The rigid deformations are assigned to a rotational matrix and a translation 
vector, where the rotation is expressed relative to the centre of mass of the scan. The rigid and non-rigid 
deformations are combined in the deformation graph by first adding the local non-rigid deformations to 
the nodes and thereafter the global rigid transformation [20].  
The source mesh deformation has to be calculated and optimised in order for the deformation graph and 
target scan to have a high correspondence, which means that each node in the deformation graph should 
have a corresponding position on the target mesh. Every node in the deformation graph is assigned an 
energy and the sum of these represent the global energy of the system. The purpose of the optimisation 
is to find the lowest energy state of the system [23]. This is an iterative process since deformations and 
correspondence between the deformation graph and the target mesh are unknown from the beginning 
[20].  
The energy in each deformation graph node is a combination of weighted parameters, which include 
similarity to connecting nodes, distance to the corresponding point on the source and target mesh and 
the deviation from local rigidity [23]. The system is also assigned with a confidence energy term which 
weight each correspondence built on how reliable the correspondence between the deformation graph 
and target is. In the source scan and target scan there might be regions without any detected object. In 
the created meshes these regions are not empty, but instead represented by deep holes. This means that 
even when regions in the source mesh have no matching region on the target mesh, each node is forced 
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to have some correspondence to the target. In the optimisation, the weight for this correspondence 
becomes zero, indicating that no suitable correspondence was found. This means that regions without 
overlap in the source and target scan do not affect the deformation. If there was no correspondence at 
regions with partial overlap many artifacts would appear in the calculated deformation and the position 
of the isocenter would not be accurately determined [20]. An illustration of how the source scan is 
connected to the target scan is presented in Figure 7.  
 
Figure 7. Illustration of the connection between the original source scan, the deformed source with its deformation graph 
and the target scan. The colour of the confidence weights indicates how well the correspondence between the deformation 
graph and the target is. [20] 
 
When the system has reached its lowest energy state, the deformation of the source matches the target 
scan and the isocenter position can be determined. A volumetric mesh that consist of tetrahedrons is 
created, where the nodes are related to the nodes in the source mesh. To determine the isocenter position, 
translation and rotation in each node of the volumetric mesh are calculated. This calculation is based on 
the source mesh deformation and the target position [23].  
The novel non-rigid PTV algorithm that can be used during the calculation of the isocenter position is 
based on including the centre of mass of the PTV to the calculation of the isocenter shift.  
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3. Materials and Methods 
Twenty-one breast cancer patients with nodal involvement were included in this study and in total 220 
treatment fractions were investigated. Out of the 21 patients, 10 were positioned with LBS. 11 patients 
were positioned with SBS. For all patients, 𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝was analysed for every fraction during which 
setup images were acquired. All patients were treated with 50 Gy in 25 fractions. 
The systematic and random setup errors were then calculated for both LBS and SBS, with and without 
the offline corrections using Eq. 1-6. The offline corrections were extracted by calculating the mean 
𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 for the first three fractions and multiply this with the correct 𝑘𝑆𝑈𝑆. The result was then either 
added to or subtracted from the original 𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 depending on if the correction was a negative or 
positive translation. 
At SUS no CTV is delineated for breast cancer patients with nodal involvement. Instead the PTV is 
directly delineated. To get an understanding of how large a margin to a possible CTV that is needed, the 
PTV margin was determined by using Eq. 9.  
To evaluate if there was a significant difference between LBS and SBS statistical tests were performed 
on the acquired setup deviation data. The absolute data in vrt, lng and lat was first tested individually 
with the Shapiro-Wilks test (α = 0.05) to determine if the data was normally distributed. If not 
normally distributed a Wilcoxon rank sum test was performed. The analysis of absolute medians for 
LBS and SBS in all directions was carried out in MATLAB. 
3.1 Patient Setup with Laser and Skin Markings 
For LBS, the deviations between the reference and the two orthogonal kV-setup images were analysed 
retrospectively in Offline Review (Aria, Varian Medical Systems, Palo Alto, CA). For these 10 patients, 
a total of 127 fractions were studied. All patients were treated at a TrueBeam linear accelerator (Varian 
Medical Systems, Palo Alto, CA) and started their treatment between the 5th of July 2016 and the 7th of 
February 2017. For LBS, the target included the breast and the locoregional lymph nodes. 
Nine patients were fixated in a PosiboardTM - 2 Breastboard (Civco Medical Solution, IA), see Figure 8, 
and one patient was fixated in a Wing Board™ (Civco Medical Solution, IA) with a vacuum bag placed 
on top. 
 
Figure 8. PosiboardTM - 2 Breastboard (http://civcort.com/ro/breast-positioning/breastboards/posiboard2-breastboard-
109030.htm)  
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𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 were retrieved for vrt, lng and lat directions by studying couch translations. The setup 
images consisted of one anterior-posterior image and one image from the right or left side, depending 
on target position. The coordinate system used for the setup deviations was based on the direction of the 
couch displacement. If the patient, and consequently the couch, had to be moved in the ventral, cranial 
or left direction for the DRR and setup images to match, the translation was positive. For the opposite 
directions, the translation was negative. The 𝜇𝐷𝑅𝑅−𝑠𝑒𝑡𝑢𝑝 values obtained from image matching by the 
treatment room staff were used.  
3.2 Patient Setup with the Catalyst System 
The 11 patients positioned with SBS started their treatment between the 27th of February 2017, and the 
6th of April 2017. Of these patients, 2 were treated at a TrueBeam linear accelerator and positioned with 
a three-camera Catalyst system. The remaining patients were treated at an Elekta linear accelerator 
(Elekta AB, Stockholm, Sweden), 4 of which were positioned with a one-camera Catalyst system, and 
5 with a three-camera system. For the patients positioned with SBS, a total of 93 fractions were analyzed.  
For 10 of the patients, the target included the whole breast and the locoregional lymph nodes. One of 
the patients had been treated with radiotherapy for breast cancer before and was now given treatment to 
the lymph nodes only, where the cancer had relapsed.  
Nine of the patients were fixated in a PosiboardTM - 2 Breastboard. One of the patients were positioned 
in a Standard Wing Board™, with a vacuum bag placed on top. For one of the patients a vacuum bag 
was placed on top of the PosiboardTM - 2 Breastboard, with the armrests removed. 
When the patients were imported to the Catalyst system an appropriate template was chosen. The 
template has a predetermined surface offset tolerance of 5 mm. The tolerance level for the isocenter shift 
was set to 2.5 mm in the vrt, lng and lat direction. These thresholds were chosen because it was low 
enough to keep the accuracy and the staff attentive to red numbers on the Catalyst computer screen, but 
not too low considering the patient motion during the time between setup and imaging. During the 
import the setting for the PTV calculation was selected and the lower part of the stomach of the patient 
was cropped from the reference surface, to avoid breathing motion from affecting the positioning.  
The staff was instructed to position the patients according to the Catalyst. This involved examining how 
well the live and reference surfaces matched and to correct for any rotation. The personnel also used the 
colormap to adjust the position and to verify the position of the arms and chin. The staff was then to 
position the patient so that the isocenter shifts were as close to zero as possible. If a bolus was used, this 
was placed on the patient before positioning according to the Catalyst. For every patient, the time and 
gain were adjusted at the first fraction to obtain the most optimal live surface. In the case of an offline 
position correction, the patient was positioned with the Catalyst, the couch correction was thereafter 
performed and a new Catalyst reference surface was acquired.  
For the patients treated at a TrueBeam, the setup deviations were retrieved in Offline Review. However, 
the setup deviations for patients treated at an Elekta were not digitally saved, but written by hand on 
paper. The orthogonal setup images were not paired for the Elekta machines and therefore two values 
for the longitudinal setup deviation were noted. In this study, an arithmetic mean of the longitudinal 
setup deviation was used. If one of the setup images taken at an Elekta machine resulted in a deviation 
exceeding the acute action level described in Table 2, a manual online correction of the couch position 
was carried out. A second image was then acquired from the same direction to ensure that the patient 
position was correct after the online correction. Since the deviations from the first image correspond to 
the correct patient position according to the Catalyst, these were the values used in this study.   
The treatment staff was asked to save the paper where the performed offline corrections were noted. 
With this information saved, the setup deviations without any offline corrections could be investigated 
with certainty of when corrections had been made.  
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3.2.1 Inter- and intrafractional Motion Induced Isocenter Shift 
For one patient, cMotion data was extracted for all fractions where the cMotion had been used during 
treatment. This patient was chosen because she occasionally moved considerably during treatment and 
was at some treatment sessions irradiated even when her movements resulted in an isocenter shift 
exceeding the threshold, see Figure 9. She was treated at the left side which made it interesting to study 
the dose to the heart.   
The bars seen in Figure 9 represent the isocenter shift vector, thus a combination of the vrt, lng and lat 
shift. For the evaluation of patient motion, the isocenter shift in the three translational directions was 
extracted for beam on. For each fraction, a mean isocenter shift in the vrt, lng and lat direction was then 
calculated for when the radiation had been delivered. To account for both intra- and interfractional 
movement, the patient’s position, registered in cPosition, was added to the isocenter shift values. This 
resulted in a new isocenter position for every fraction investigated, including both the setup deviations 
and movements of the patient. In total cMotion data could be extracted for 23 fractions. For the two 
remaining fractions no isocenter shift was performed, and the original isocenter position was retained in 
the TPS. 
The patient’s original treatment plan was copied 25 times in the treatment planning system (TPS) 
Eclipse™ (Varian Medical Systems, Palo Alto, CA) and for each plan the position of the isocenter was 
changed according to the calculated mean shifts for each fraction. The treatment plan was then 
recalculated using the same number of monitor units as the original plan. This means that the radiation 
would have been delivered with the same settings as the actual delivered dose to the patient, but with a 
different isocenter position, resulting in a different dose distribution for every fraction. The dose 
distributions for the 25 isocenter-shifted plans were then summed. This summed dose distribution, with 
the motion of the isocenter taken into account, was then compared to the original dose distribution by 
comparing the resulting dose volume histogram (DVH).  
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(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 9. Example of cMotion data from fraction 18 with low patient movement (a) and fraction 2 (b), fraction 13 (c) and fraction 
22 (d) with large patient motion, for the patient whose motion was evaluated. 
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4. Results 
Figure 10 shows histograms displaying the distribution of setup deviations for LBS and SBS, both with 
and without the offline corrections. For LBS 44 %, 31% and 36% of the setup deviations exceeded the 
clinical threshold of 4 mm in the vrt, lng and lat direction respectively when the offline corrections were 
excluded (Figure 10(a)). The range of setup deviation was -10.0–10.4 mm, -11.8–12.7 mm, -8.6–12.2 
mm in the vrt, lng and lat direction respectively. By using the correction strategy, the amount of fractions 
where the patient position exceeded 4 mm was reduced to 22 % in the vrt direction, 21 % in the lng 
direction and 28 % in the lat direction (Figure 10b). The range of setup deviation was also decreased. 
With the offline corrections performed included, the range of setup deviations was -10.0–8.7 mm, -11.8–
8.6 mm and -8.6–9.2 mm in the vrt, lng and lat direction respectively. 
Using SBS, the amount of setup deviations exceeding 4 mm was further reduced. Without the correction 
strategy 7.5 % of the setup deviations exceed 4 mm in the vrt direction, 7.5 % in the lng direction and 
27 % in the lat direction (Figure 10c). The deviations ranged between -5.7‒5.4 mm, -5.6‒5.1 mm and 
7.9‒7.0 mm in the vrt, lng and lat direction respectively. By performing offline corrections during the 
treatment course 7.5 % of the setup deviations exceeded the clinical threshold of 4 mm in the vrt 
direction. The corresponding values for the lng and lat direction were 6.5 % and 20 % respectively. The 
deviations ranged from -5.7‒5.4 mm in the vrt direction, -5.6‒3.7 mm in the lng direction and -7.9‒6.0 
in the lat direction. 
The Shapiro-Wilks test showed that the data representing the distribution of absolute setup deviations 
for LBS and SBS was not normal in any direction. The Wilcoxon rank sum test was used with the 
following null hypothesis: There is no difference in the absolute median between LBS and SBS. The test 
was performed with a significance level of 0.05 and this was done for all three directions (Table 3). 
Figure 11 shows a comparison between LBS and SBS in the form of cumulative histograms for the 
absolute value of the setup deviations in the vrt, lng and lat direction. The histograms show the 
cumulative probability to position the patient within a certain deviation between the planned and daily 
position. For instance, without the use of a correction strategy there was a 58 % probability of positioning 
a patient within a deviation of 4 mm in the vrt direction with LBS. For SBS, the corresponding 
probability was 94 % (Figure 11a).  
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(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 10. Histograms showing patient setup deviations in the vrt, lng and lat direction for LBS without offline corrections (a), LBS with offline corrections 
(b), SBS without offline corrections (c) and SBS with offline corrections. and SBS.  
 
Table 3. The absolute median for the setup deviations in vrt, lng and lat for LBS and SBS with the associated p – values. 
 Vrt – Median (range)  
[mm] 
Lng – Median (range)  
[mm] 
Lat – Median (range)  
[mm] 
LBS 2.7 (0 – 10.0) 2.0 (0 – 11.8) 2.6 (0 – 9.2) 
SBS 1.7 (0 – 5.7) 1.0 (0 – 5.6) 1.5 (0 – 7.9) 
p 0.067 0.014 0.005 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
Figure 11. Cumulative histograms for LBS (green) and SBS (blue) in the vrt direction without offline corrections (a), vrt direction with offline 
corrections (b), lng direction without offline correction (c), lng direction with offline correction (d), lat direction without offline correction (e) 
and lat direction with offline corrections (f). The dashed vertical lines mark the 4 mm setup deviation threshold. 
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4.1 Setup Deviations and PTV margins 
The resulting overall mean systematic deviation for LBS and SBS is presented in Table 4. The overall 
mean systematic deviation was calculated for the data without the correction strategy (𝑚o,LBS and 𝑚o,SBS) 
and for data including the correction strategy (𝑚o,LBS,c and 𝑚o,SBS,c). 𝑚o,LBS was found to be statistically 
significant in the lat direction, which indicates that without the correction strategy, there would be a 
systematic deviation that affects all patients if they are setup with LBS. However, there was no statistical 
significance for when the correction strategy was applied. 
The systematic error for LBS and SBS is shown in Table 5. The systematic error was determined for 
when the offline corrections were excluded (𝛴𝐿𝐵𝑆 and 𝛴𝑆𝐵𝑆) and included (𝛴𝐿𝐵𝑆,𝑐 and 𝛴𝑆𝐵𝑆,𝑐). The 
random setup error for LBS and SBS was also determined for both when the correction strategy was 
excluded (𝜎𝐿𝐵𝑆 and 𝜎𝑆𝐵𝑆) and included (𝜎𝐿𝐵𝑆,𝑐 and 𝜎𝑆𝐵𝑆,𝑐) (Table 6). Individual systematic and random 
deviations for each patient for both LBS and SBS are presented in Appendix 1. 
Using the determined systematic and random setup errors the PTV margin was determined, both without 
(𝑃𝑇𝑉𝑚,𝐿𝐵𝑆 and 𝑃𝑇𝑉𝑚,𝐿𝐵𝑆,𝑐) and with offline corrections (𝑃𝑇𝑉𝑚,𝐿𝐵𝑆,𝑐 and 𝑃𝑇𝑉𝑚,𝑆𝐵𝑆,𝑐), see Table 7. 
Table 4. The overall mean systematic deviation in the vrt, lng and lat directions for LBS without offline corrections 
(𝑚o,LBS), LBS with offline corrections (𝑚o,LBS,c), SBS without offline corrections (𝑚o,SBS) and SBS with offline corrections (𝑚o,SBS,c). * 
indicates a value that is statistically significantly non-zero. 
 Overall mean systematic deviation  
 𝑚o,LBS 𝑚o,LBS,c 𝑚o,SBS 𝑚o,SBS,c 
Vrt [mm] 0.72 0.85 -0.07 0.05 
Lng [mm] 0.75 0.57 -0.42 -0.59 
Lat [mm] 1.2* 0.78 -0.11 -0.32 
 
 
Table 5. The systematic setup error in the vrt, lng and lat directions for LBS without offline corrections (𝛴𝐿𝐵𝑆), LBS with offline corrections 
(𝛴𝐿𝐵𝑆,𝑐), SBS without offline correction (𝛴𝑆𝐵𝑆)  and SBS with offline corrections (𝛴𝑆𝐵𝑆,𝑐). 
 Systematic error  
 𝛴𝐿𝐵𝑆 𝛴𝐿𝐵𝑆,𝑐 𝛴𝑆𝐵𝑆 𝛴𝑆𝐵𝑆,𝑐 
Vrt [mm] 2.4 1.7 1.7 1.7 
Lng [mm] 2.1 2.4 1.3 1.4 
Lat [mm] 1.6 2.9 2.6 2.1 
 
 
Table 6. The random setup error in the vrt, lng and lat directions for LBS without offline corrections (𝜎𝐿𝐵𝑆), LBS with offline corrections 
(𝜎𝐿𝐵𝑆,𝑐), SBS without offline correction (𝜎𝑆𝐵𝑆)  and SBS with offline corrections (𝜎𝑆𝐵𝑆,𝑐). 
 Random error  
 𝜎𝐿𝐵𝑆 𝜎𝐿𝐵𝑆,𝑐 𝜎𝑆𝐵𝑆 𝜎𝑆𝐵𝑆,𝑐 
Vrt [mm] 4.3 3.1 1.9 1.9 
Lng [mm] 4.5 2.9 1.8 1.5 
Lat [mm] 3.9 3.4 2.1 2.1 
 
 
Table 7. The PTV margin in the vrt, lng and lat direction for LBS without offline corrections (𝑃𝑇𝑉𝑚,𝐿𝐵𝑆), LBS with offline 
corrections (𝑃𝑇𝑉𝑚,𝐿𝐵𝑆,𝑐), SBS without offline corrections (𝑃𝑇𝑉𝑚,𝑆𝐵𝑆) and SBS with offline corrections (𝑃𝑇𝑉𝑚,𝑆𝐵𝑆,𝑐).  
 𝑷𝑻𝑽𝒎,𝑳𝑩𝑺  𝑷𝑻𝑽𝒎,𝑳𝑩𝑺,𝒄  𝑷𝑻𝑽𝒎,𝑺𝑩𝑺  𝑷𝑻𝑽𝒎,𝑺𝑩𝑺,𝒄  
Vrt [mm] 9.0 6.0 6.0 6.0 
Lng [mm] 9.0 8.0 5.0 5.0 
Lat [mm] 7.0 7.0 8.0 7.0 
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4.2 Dosimetric Effect of Inter- and intrafractional Motion  
In Figure 12 the DVH of the original treatment plan and the treatment plan based on the mean isocenter 
shift for each fraction is shown. At SUS the highest priority for the treatment plan for breast cancer 
patients with nodal involvement is D98% ≥ 93 % for thePTV and 93 % of 50 Gy is 46.5 Gy. D98% for the 
original plan was 46.6 Gy. D98% for the plan where the isocenter has been shifted for each fraction to a 
calculated mean position was 46.5 Gy. In Table 8 and Table 9 D98% to the PTV, D2%  to the OAR and 
the mean absorbed doses are presented for both treatment plans.  
 
 
Figure 12. The DVH of the original treatment plan (squares) and the treatment plan resulting from a mean isocenter shift (triangles) for the PTV (blue), left 
ung (green), heart (purple) spinal cord (yellow) and total body volume (orange). 
 
 
Table 8. The D98% and the mean absorbed dose to the PTV. 
 D98% [Gy] Mean Dose [Gy] 
Structure Original Mean Iso shift Original  Mean Iso shift 
PTV 46.6 46.5 50.0 50.0 
 
 
 
Table 9. The D2% and the mean absorbed dose to the OAR. 
 D2% [Gy] Mean Dose [Gy 
Structure Original Mean Iso shift Original  Mean Iso shift 
Left lung 47.8 47.6 14.4 13.9 
Heart 14.1 11.5 2.16 2.00 
Spinal cord 4.77 5.79 2.72 2.90 
Body 50.3 50.3 5.42 5.32 
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5. Discussion 
The optical surface scanning system Catalyst have in previous work been proven to be an accurate 
method for patient positioning  [6], [7], [12]. The studies by Kügele et al. [6] and Crop et al. [7] also 
showed that patient positioning with the Catalyst is superior to the patient setup with laser and skin 
markings. In consistency with the mentioned studies, the results presented in this master thesis indicate 
that the Catalyst is a better method of positioning breast cancer patients with nodal involvement, 
compared to laser and skin markings. 
When studying Figure 10a it can be seen that positioning with laser and skin markings resulted in a large 
amount of fractions exceeding the clinical setup deviation threshold of 4 mm. Without offline 
corrections, nearly half of the fractions would exceed 4 mm in the vrt direction. When the correction 
strategy was included, the setup deviations were smaller and the number of fractions exceeding 4 mm 
was reduced (Figure 10b). For instance, the number of fractions where a patient was positioned outside 
the 4 mm threshold was reduced to halved in the vrt direction when the offline corrections were included. 
This indicate that the correction strategy is useful and beneficial for breast cancer patients with nodal 
involvement using LBS. However, even with a correction strategy, there were still a considerable 
amount of fractions with deviations larger than the threshold. For example, in the lateral direction, 28 
% of the fractions exceeded the clinical deviation threshold. This implies that for LBS, the patient is not 
positioned correct in the lat direction for almost a third of all treatment sessions without setup imaging. 
The results further indicate that positioning exceeding the threshold for what is clinically acceptable in 
the vrt and lng directions occurs approximately 20 % of all fractions without setup imaging.  
The results presented in Figure 10c and d show a distinct improvement in patient positioning for SBS 
compared to LBS and the amount of setup deviations exceeding 4 mm was reduced in all directions for 
SBS. This reduction explains why the histograms in Figure 10c and d do not have as long tails as the 
histograms in Figure 10a and b.  
In the vrt and lat direction, 7.5 % of the setup deviations exceeded 4 mm. These results indicate that, on 
average, patient positioning with more than 4 mm setup deviation vertically or longitudinally from the 
planned position occurred only two times during the whole treatment course for one patient. This ensures 
that the Catalyst could be used as a tool for patient setup during fractions when imaging is not performed. 
However, the amount of setup deviations exceeding 4 mm was not decreased as much in the lateral 
direction, which indicates that this was the direction the staff thought was most difficult to position 
correctly with the Catalyst. The position of the arm affects the value of the lateral isocenter shift 
relatively much. It is possible that the treatment staff did not position the arm correctly at every fraction. 
This was a new way for the personnel to position this category of patients and the lateral setup of the 
patient will most likely improve if the personnel continue to position with the Catalyst and gain even 
more experience of this method. Even so, SBS did reduce the lateral setup deviations and would be the 
preferred setup method for this direction as well.  
As can be seen in Figure 10c and d, there is not a large difference between the histograms with and 
without offline corrections for SBS. The amount of setup deviations that exceeded 4 mm is slightly 
higher for the data without offline corrections. This implies that although the correction strategy is 
beneficial for the patients positioned according SBS, it is not as important as when positioning with 
LBS. 
The results presented in Table 3 confirms that there is a statistical significant difference between LBS 
and SBS in the lng and lat direction and SBS significantly improve the patient position.  
The cumulative histograms of the setup deviations presented in Figure 11, show that the cumulative 
histogram for LBS is in principle always under that for SBS, regardless of the deviation direction. This 
implies that the probability for positioning a patient within a given setup deviation was higher for SBS. 
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The figures also illustrates how the different setup methods were affected by the correction strategy. For 
LBS, a difference can be seen when comparing the cumulative histograms with and without offline 
corrections. For instance, the probability of positioning a patient within 4 mm in the vrt direction without 
oflline corrections was 58 %, as mentioned in section 4. With the use of the correction strategy the 
corresponding value was 78 %. However, the cumulative histograms representing SBS do not differ to 
any large extent between excluding and including offline corrections. The probability for positioning a 
patient within a 4 mm in the vrt direction, using SBS, was 94 % both with and without offline 
corrections. This further confirms that LBS is more dependent on the correction strategy, while SBS 
provides a high setup accuracy and is a stable setup method, even without a correction strategy.  
5.1 Setup Deviations and PTV margins 
The results presented in Table 5 show that the systematic error was decreased when the Catalyst was 
used for patient setup and the correction strategy was applied. This implies that the mean patient position 
deviated less from the planned position for SBS and using the Catalyst during setup is the more accurate 
patient positioning method. For LBS both the lng and lat systematic error was increased when the offline 
correction were applied. This could be an indication of that the correction strategy used at SUS for 
decreasing the systematic setup deviations may not be the most optimal strategy for breast cancer 
patients with nodal involvement. 
The random setup error was decreased as well for SBS, for all directions (Table 6). This means that the 
Catalyst did not only lead to more accurate setup, but a more precise setup as well. While it might not 
be the most optimal correction strategy, the strategy does seem to improve the setup precision for 
patients positioned with LBS. The difference between including and excluding offline corrections was 
however much smaller for SBS.  
Further results confirming that the Catalyst offers a more accurate and precise setup method for breast 
cancer patients with nodal involvement can be seen in Table 10 - Table 13, Appendix 1, where the 
individual systematic and random deviations are presented. It should be noted that for patient 6 the 
random deviation without offline correction was almost 1 cm. When the correction strategy was 
included, both the systematic and random deviation were still larger than 4 mm. This implies that for 
LBS a patient could be positioned outside of the clinical threshold for setup deviation most of the 
treatment sessions. Such large deviations were not seen for any patient positioned with SBS. 
The PTV margin required to account for both the systematic and random setup error could be reduced 
in the lng direction for patients positioned with SBS, using the correction strategy (Table 7). This means 
that the Catalyst requires a smaller PTV than laser and skin markings and more healthy tissue could then 
be spared.  
Some assumption had to be made regarding the offline corrections made for LBS, since no certain 
documentation of offline corrections was available after the patient had finished the treatment. If there 
were no other indications, an offline correction was assumed to have been made after the three first 
fractions and none after this. When information in Offline Review indicated that an offline correction 
should be done, it was assumed that a correction was performed, regardless of which fraction it 
concerned. In two cases information in Offline Review, in combination with a new acquired Catalyst 
surface reference, indicated that offline corrections had been performed. This means that the number of 
offline corrections actually performed may differ from the number of offline corrections assumed to 
have been performed. The number of offline corrections actually performed is probably larger than 
assumed, since all possible, but not definite, corrections after the one done after the first three fractions 
were disregarded. The setup deviations without offline corrections could therefore actually be larger 
than presented here. Since all papers with notations on performed offline corrections were saved for the 
patients positioned according to the Catalyst, there is here no uncertainty of when offline corrections 
were performed. 
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Another uncertainty in the data is the inter-observer variability of matching the reference and daily 
verification images. Different persons might match the images against different anatomical landmarks 
which give differences in the setup deviation results. If the image quality differs from what the observer 
is used to, it can also affect the result. In this study only deviations from image matching performed by 
the treatment room staff, were used. Image matching is also performed by a physicist after treatment, 
but including the physicist’s match would have increased the inter-observer variability. There is a 
limited number of persons working in the treatment rooms, but the physicist who does the image 
matching varies from day to day.  The setup deviations that resulted from the treatment staffs’ image 
matching also represented the position in which the patient had been given the treatment.   
5.2 Dosimetric Effect of Inter- and Intrafractional Motion  
The dosimetric result from calculating a mean position for the isocenter during beam on did not differ 
to any large extent from the original treatment plan. The PTV coverage still met the clinical requirement 
and the mean absorbed dose to the heart and left lung was slightly lower than in the original plan. This 
means that despite the large patient motion during treatment, she still received a dose distribution close 
to the planned one, which is reassuring. The absorbed dose to the spinal cord was slightly increased, but 
the clinical impact of this increase is probably small.  
The treatment room personnel for the investigated patient are all very experienced and skilled in 
positioning breast cancer patients with nodal involvement according to the Catalyst. Even though the 
patient moved a lot during some treatment sessions, the accurate patient positioning may have been a 
contributing factor to the small difference between the original treatment plan and the re-calculated one. 
Investigating a patient without distinctive movement during treatment, but with an inferior setup might 
show a different result.  
It may also be that this patient moved in a way, for instance by relaxing more during the treatment 
session, that prevented the heart and lung from receiving a higher absorbed dose. 
Perhaps analysing the mean isocenter shift during beam on is not the most representative method for 
determining how the dose distribution is affected by patient motion. It might be more accurate to extract 
the isocenter shift for every, individual field instead. As can be seen in Figure 9 the patient tended to 
drift from the initial position and the isocenter shift was larger during the last fields. The result from 
analysing each field individually might result in a different absorbed dose to the OAR most affected by 
the later radiation fields. 
As can be seen in Figure 9 the patient has been irradiated although the isocenter vector shift exceeded 4 
mm. At SUS, no automatic beam interruption for free breathing breast cancer patients with nodal 
involvement has been installed. The Catalyst system is, at the moment, used only as a tool to aid the 
treatment personnel during the patient positioning and monitoring of the patient. The Catalyst is not 
included in our method for this patient category and it is therefore not a requirement to use the Catalyst 
during patient positioning and the beam does not have to be interrupted if the patient moves to a large 
extent during the treatment. Before including positioning and monitoring the patient with the Catalyst, 
the method has to be evaluated. The results in this thesis indicate that the patient positioning would be 
improved using the Catalyst. However, the impact of patient motion during treatment has to be further 
investigated in order to determine an appropriate threshold for the isocenter vector shift. According to 
this evaluation, the patient investigated did receive a dose distribution close to the planned one. 
However, any conclusions about how patient movement during the treatment affects the dose 
distribution cannot be drawn from information from only one patient, and therefore more patients need 
to be evaluated. 
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6. Conclusion 
Positioning breast cancer patients with nodal involvement using SBS resulted in fewer setup deviations 
exceeding the clinical acute action level of 4 mm, compared to LBS. Using SBS also led to a smaller 
systematic error, which means that the mean patient position was improved. The random error was 
decreased as well and the risk of large, random setup deviations was thereby decreased.  
According to this study, using a correction strategy for breast cancer patients with nodal involvement is 
important for patients positioned with LBS. However, a similar difference between using and not using 
a correction strategy could not be seen for SBS. This indicates that the Catalyst provides a reliable 
method for patient positioning.  
These results indicate that the Catalyst can improve the patient positioning and provide higher accuracy 
and precision during setup compared to setup with laser and skin markings. They also reassure that the 
patient can be positioned correctly even during the fractions where no verification images are acquired. 
The evaluation of the dosimetric effect of inter- and intrafractional motion, for one of the patients in this 
study, indicated only a small impact on the PTV coverage and OAR doses. The differences in the dose 
distributions were not clinically relevant. However, to be able to draw any definite conclusions about 
the dosimetric effect due to patient motion more patients have to be evaluated. 
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7. Future prospects 
The purpose of this master thesis was to evaluate if patient positioning was improved using the optical 
surface scanning system Catalyst. The study showed that positioning leads to smaller systematic and 
random errors and more patients are positioned within the clinical tolerance for deviation. However, in 
the future it would be interesting to acquire more data and involve a greater number of patients to 
improve the statistics of this study. 
As mentioned in section 5.2 it would be possible to extract the mean isocenter position for every 
individual field during each treatment session, instead of assuming the same mean isocenter shift for all 
fields. Evaluating every field separately would represent the motion of the patient better and would give 
better estimate of how the PTV coverage and OAR doses are affected by the motion.  
To be able to draw any conclusions about how patient motion during treatment affect the dose 
distribution more patients will have to be evaluated. It would also be interesting to investigate patients 
who have been setup with LBS, but have also been motion monitored with cMotion. This would provide 
the possibility to investigate if the improved patient positioning observed with SBS also results in a 
dosimetric benefit. 
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Appendix 1 
In Table 10 and Table 11 the individual systematic deviation is presented for LBS and SBS respectively. 
The systematic deviation in the vrt, lng and lat direction is presented for both the correction strategy 
excluded and included. 
The individual random setup error is presented in Table 12 and Table 13 for LB and SB respectively. 
The random deviations, both with and without offline corrections in the vrt, lng and lat direction is 
shown. 
 
Table 10. The individual systematic deviation for patients positioned with LBS, for both without (𝑚𝑝,𝐿𝐵𝑆) and with 
(𝑚𝑝,𝐿𝐵𝑆,𝑐) offline corrections. 
 Vrt [mm] Lng [mm] Lat [mm] 
Patient 𝑚𝑝,𝐿𝐵𝑆 𝑚𝑝,𝐿𝐵𝑆,𝑐 𝑚𝑝,𝐿𝐵𝑆 𝑚𝑝,𝐿𝐵𝑆,𝑐 𝑚𝑝,𝐿𝐵𝑆 𝑚𝑝,𝐿𝐵𝑆,𝑐 
1 0.58 0.58 -0.92 2.8 -2.5 -2.5 
2 4.1 1.5 2.3 2.3 1.5 1.5 
3 -1.2 0.85 -0.28 -2.3 3.2 3.6 
4 -0.23 -2.7 1.6 1.6 1.1 1.1 
5 -2.6 1.7 2.6 2.6 2.3 2.3 
6 3.1 3.1 4.1 -4.3 -0.31 -0.31 
7 1.1 1.1 0.64 0.64 -0.14 -0.14 
8 -0.94 -0.94 -2.4 0.70 0.72 0.72 
9 1.4 -1.9 -0.92 1.7 1.2 -2.8 
10 0.05 2.4 -1.7 -1.7 2.8 1.2 
 
 
Table 11. The individual systematic deviation for patients positioned with SBS. Values for both without (𝑚𝑝,𝑆𝐵𝑆) and 
with (𝑚𝑝,𝑆𝐵𝑆,𝑐) a correction strategy is shown.  
 Vrt [mm] Lng [mm] Lat [mm] 
Patient 𝑚𝑝,𝑆𝐵𝑆 𝑚𝑝,𝑆𝐵𝑆,𝑐 𝑚𝑝,𝑆𝐵𝑆 𝑚𝑝,𝑆𝐵𝑆,𝑐 𝑚𝑝,𝑆𝐵𝑆 𝑚𝑝,𝑆𝐵𝑆,𝑐 
11 -0.50 -0.50 0.86 0.86 0.43 0.43 
12 1.1 1.1 -2.9 -2.9 4.8 2.6 
13 -2.6 -0.64 -1.2 -1.2 -3.5 -3.1 
14 0.31 0.31 -0.16 -2.4 0.19 0.19 
15 -2.1 -2.1 -0.04 -0.04 1.3 1.3 
16 1.1 1.1 -1.8 -1.8 -2.1 -2.1 
17 -2.4 -3.2 0.08 0.08 -1.1 -1.1 
18 1.7 1.7 1.5 1.5 -2.1 -2.1 
19 1.3 1.3 -0.3 -0.3 -2.4 -2.4 
20 2.1 2.1 0.12 0.12 0.89 0.89 
21 -0.81 -0.81 0.21 0.21 2.7 2.7 
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Table 12. The individual random deviation for patients setup with LBS, for both without (σp,LBS) and with (σp,LBS,c) offline 
corrections. 
 Vrt [mm] Lng [mm] Lat [mm] 
Patient σp,LBS σp,LBS,c σp,LBS σp,LBS,c σp,LBS σp,LBS,c 
1 2.2 2.2 5.2 2.9 1.3 1.3 
2 3.9 3.2 2.7 2.7 3.2 3.2 
3 5.1 3.4 4.0 2.6 2.9 2.0 
4 4.7 3.3 1.5 1.5 1.9 1.9 
5 6.8 4.2 2.3 2.3 4.0 4.0 
6 2.7 2.7 9.7 4.7 2.9 2.9 
7 2.4 2.4 2.7 2.7 3.4 3.4 
8 3.1 3.1 4.9 3.3 4.5 4.5 
9 5.3 3.2 4.7 2.8 6.7 3.8 
10 3.0 2.2 2.8 2.8 5.4 4.1 
 
 
Table 13. The individual random setup deviation for without (σp,SBS) and with (σp,SBS,c) the correction strategy in the 
vertical, longitudinal and lateral direction for patient positioned with SBS. 
 Vrt [mm] Lng [mm] Lat [mm] 
Patient σp,SBS σp,SBS,c σp,SBS σp,SBS,c σp,SBS σp,SBS,c 
11 1.5 1.5 1.2 1.2 1.8 1.8 
12 2.9 2.9 1.6 1.6 1.7 2.3 
13 0.77 2.0 1.5 1.5 2.2 2.2 
14 1.1 1.1 4.7 2.7 0.64 0.64 
15 1.6 1.6 0.83 0.83 2.2 2.2 
16 1.0 1.0 1.2 1.2 1.8 1.8 
17 2.4 1.3 0.83 0.83 1.9 1.9 
18 1.9 1.9 0.86 0.86 3.0 3.0 
19 2.0 2.0 1.4 1.4 2.7 2.7 
20 2.0 2.0 1.8 1.8 1.2 1.2 
21 2.3 2.3 2.2 2.2 2.0 2.0 
 
 
